Avalo Therapeutics (AVTX) EBITDA (2014 - 2026)
Avalo Therapeutics (AVTX) reported EBITDA of -$31.5 million for Q2 2026, compared with -$19.18 million a year earlier.
Powered by 
Analysis
Avalo Therapeutics (AVTX) EBITDA (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Avalo Therapeutics' EBITDA came in at -$91.25 million; for FY2025, it was -$72.58 million.
- By year, EBITDA came in at -$68.34 million in FY2024, -$27.19 million in FY2023, -$37.27 million in FY2022 and -$80.48 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly EBITDA since Q1 2024.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$20.88 million (Q1 2026), -$19.73 million (Q4 2025) and -$19.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Avalo Therapeutics | 386.09 Mn | -587.48 Mn | - | -23.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -23.38 Mn |
| Jun 30, 2026 | -31.50 Mn |
| Mar 31, 2026 | -20.88 Mn |
| Dec 31, 2025 | -19.73 Mn |
| Sep 30, 2025 | -19.14 Mn |
| Jun 30, 2025 | -19.18 Mn |
| Mar 31, 2025 | -14.53 Mn |
| Dec 31, 2024 | -13.24 Mn |
| Sep 30, 2024 | -12.83 Mn |
| Jun 30, 2024 | -9.54 Mn |
| Mar 31, 2024 | -32.73 Mn |
| Dec 31, 2023 | -7.62 Mn |
| Sep 30, 2023 | -2.58 Mn |
| Jun 30, 2023 | -6.76 Mn |
| Mar 31, 2023 | -8.41 Mn |
| Dec 31, 2022 | -8.47 Mn |
| Sep 30, 2022 | 4.48 Mn |
| Jun 30, 2022 | -11.46 Mn |
| Mar 31, 2022 | -20.44 Mn |
| Dec 31, 2021 | -17.32 Mn |
API Access
Avalo Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();